Changing the story of cancer

Changing the story of cancer

Changing the story of cancer

event Saturday, September 23, 2023 schedule 9.00am - 9.45am BST
Booking closed
Booking closed
event Saturday, September 23, 2023 schedule 9.00am - 9.45am BST
  • Rebecca Fitzgerald with cancer-testing device
In-person at Sidgwick | £15
Open to: 
Alumni and guests
Health and medicine, Science and technology
Sidgwick Site | View details

Find the session recording below.

Cambridge Cancer Research Hospital will change the story of cancer.  It will bring together clinical and research expertise in a new, world-class hospital, designed in partnership with our patients. We will detect cancer earlier, treat it more precisely and save more lives. What happens here in Cambridge will have a huge impact across the region, the UK and the world. The breakthroughs and innovations we deliver will change the way we detect and treat cancer far beyond our hospital, bringing hope to millions of people.

Join Professor Rebecca Fitzgerald and Professor Jean Abraham as they discuss the new Cambridge Cancer Research Hospital, where clinicians and cancer researchers are co-located with physicists, engineers, mathematicians and computational scientists, to create innovative approaches that will dramatically improve patient care.

Changing the Story of Cancer


Professor Rebecca Fitzgerald

Professor Rebecca Fitzgerald

Rebecca Fitzgerald is Professor of Cancer Prevention at the University of Cambridge and Director, Early Cancer Institute.

She still practices medicine as an Honorary Consultant in Gastroenterology at Addenbrooke's Hospital, Cambridge. 

She studied Medicine at Cambridge University and gained her MD in 1997 following a period of research at Stanford University, California, with Professor George Triadafilopoulos. Her postdoctoral training took place at the Department of Adult and Paediatric Gastroenterology, St Barts and The Royal London School of Medicine and Dentistry with Professor Michael Farthing, funded by an MRC Clinician Scientist award. She returned to Cambridge in 2001 to form her own group and since then her work has been funded by CRUK and MRC. In 2022 she founded a new institute to bring together clinicians and scientists from multiple disciplines to make breakthroughs in detecting cancer earlier.

The focus of her research group is understand how cancer of the oesophagus and stomach develops and use this to develop new diagnosis and screening tests. Rebecca was awarded the prestigious Westminster medal and prize for her first proof-of-concept work on the CytospongeTM and associated assays for diagnosing precancer of the oesophagus, Barrett oesophagus, in 2004. She received a Lister Prize Fellowship in 2008 and in 2013 was awarded an NIHR Research Professorship to facilitate translational research for patient benefit. She was elected a Fellow of the Academy of Medical Sciences in 2013, in 2021 she was awarded the Don Listwin Award for Outstanding Contribution to Cancer Early Detection and she received an OBE for services to cancer medicine in 2022.

Rebecca has a wealth of lecturing experience including radio broadcasts for BBC Radio 4 and ABC Radio Australia, Health of the Nation. Rebecca is a Fellow of Trinity College Cambridge and committed to teaching and inspiring the next generation of clinical researchers.

Professor Jean Abraham

Jean Abraham

Professor Jean Abraham is Director of the Cambridge Breast Cancer Research Unit, and an Academic Honorary Consultant in Medical Oncology in Cambridge. She co-leads the Integrated Cancer Medicine (ICM) theme in the Cancer Research UK Cambridge Centre, with oversight of the Cancer Molecular Diagnostics Laboratory, ICM Clinical Trials and Tissue Bank Rapid Response Team. Jean is also deputy theme lead for Cancer at the Cambridge NIHR Biomedical Research Campus. She is part of the national NIHR Clinical Studies Group for Breast Cancer and part of the NCRI Working Party for Early Disease. She graduated from the University of Liverpool Medical School and trained in Internal Medicine and Oncology at the University of Cambridge. She was awarded a National CRUK PhD Fellowship, receiving her PhD in Breast Cancer Pharmacogenetics from the University of Cambridge (2011). In 2017 she was awarded the BioBeat Award for Top 50 Females in UK BioBusiness and Healthcare and a Royal Society Award to enable closer links between academics/scientists and policy makers.

The goal of her research is to identify better ways to personalise breast cancer treatments, avoiding overtreatment and unnecessary toxicity and providing better clinical outcomes.

Booking information

In-person lectures at the Sidgwick Site as part of Alumni Festival cost £15 per person.


Booking for this event is now closed.


Sidgwick Site
West Road
United Kingdom


Events Team